Nutritional Status in Children With ALL in Guatemala
NCT03471416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109
Last updated 2024-05-29
Summary
This study proposes to investigate the association of nutritional status of a children assessed by body mass index (BMI), triceps skinfold thickness (TSFT), and mid upper arm circumference (MUAC), with body composition, measured by dual-energy X-ray absorptiometry (DEXA), in 60 children undergoing treatment of ALL at Unidad Nacional de Oncologia Pediatrica (UNOP), in Guatemala City, Guatemala. The study also aims to establish normative values of body composition in children residing in an LMIC by examining 160 healthy siblings of children under treatment, and to measure habitual physical activity in children with acute lymphoblastic leukemia (ALL) at diagnosis and during therapy.
Conditions
Sponsors & Collaborators
-
Unidad nacional de Oncologia Pediatrica, Guatemala
collaborator OTHER - lead OTHER
Principal Investigators
-
Ronald Barr, MB, ChB, MD · McMaster University
-
Federico Antiloon, MD, MMM, PhD · Unidad Nacional de Oncología Pediátrica
-
Elena J Ladas, RD, PhD · Columbia University
Eligibility
- Min Age
- 3 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-01
- Primary Completion
- 2022-09-01
- Completion
- 2022-09-01
Countries
- Guatemala
Study Locations
More Related Trials
-
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
NCT01057290 ·Status: COMPLETED
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
NCT05929976 ·Status: RECRUITING
-
Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT02642965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia
NCT00900445 ·Status: WITHDRAWN
-
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia
NCT01642121 ·Status: COMPLETED
-
FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years
NCT00254410 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
NCT01540578 ·Status: COMPLETED
-
A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT
NCT00460421 ·Status: COMPLETED ·Phase: PHASE1
-
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735 ·Status: RECRUITING
-
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia
NCT01625143 ·Status: COMPLETED
-
Childhood Acute Lymphoblastic Leukaemia: Follow-Up
NCT03545659 ·Status: COMPLETED
-
Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia
NCT01438138 ·Status: COMPLETED
-
Early Diagnosis of Leukemic Children Patients Based on Clinical, Age Estimation and Radiographical Evaluation of Oral Affection
NCT04756258 ·Status: COMPLETED
-
Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children
NCT00287105 ·Status: COMPLETED ·Phase: PHASE2
-
Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
NCT06918054 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
NCT03647124 ·Status: COMPLETED
-
Study on Two Different Formulations of 6-mercaptopurine. Tablet Versus Oral Liquid
NCT01906671 ·Status: UNKNOWN ·Phase: PHASE4
-
Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)
NCT00206726 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421
NCT01035307 ·Status: COMPLETED
-
Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia
NCT04699162 ·Status: COMPLETED
-
Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.
NCT01041508 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
NCT00268528 ·Status: COMPLETED
-
Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy
NCT07313878 ·Status: RECRUITING ·Phase: NA
-
Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia
NCT04562792 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients
NCT07039877 ·Status: RECRUITING ·Phase: PHASE2